Summary
ONE of the leading lights of Scotland's volatile biotech sector is facing collapse, after a key backer pulled out of a new funding round.
ExpressOn BioSystems, which has pioneered research into "blocking" defective human genes, will crash into insolvency next weekwithout a fresh cash injection.See the full content of this document
Extract
Flagship Scottish Biotech On Brink of Collapse Key Backer Pulls Out of New Funding Round
The Scottish Enterprisebacked firm, based at the Roslin Biocentre in Midlothian, has already begun moves to wind itself up. A creditors' meeting is scheduled for next Tuesda...
See the full content of this document
Sponsored links
